Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand.
about
The Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseDengue: Moving from Current Standard of Care to State-of-the-Art TreatmentTissue tropisms, infection kinetics, histologic lesions, and antibody response of the MR766 strain of Zika virus in a murine modelDengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infectionThe Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.Infectious dengue vesicles derived from CD61+ cells in acute patient plasma exhibited a diaphanous appearanceNeutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice.Vertebrate Reservoirs of Arboviruses: Myth, Synonym of Amplifier, or Reality?Homotypic Dengue Virus Reinfections in Nicaraguan Children.Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys.Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial.The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection.
P2860
Q26995782-5C8B38A8-BF1A-40F8-B37F-C79B4772F1C6Q27010609-95505BB4-F5D3-460F-BDD9-6C0A123CB3F6Q29572516-F57641FD-4DC3-4328-98FC-F2163923F747Q34351011-106688D2-D87A-4741-9594-272CCA18055BQ35601805-B6E59BD5-C296-4DF7-8433-884B664DFD8EQ36206719-101D172B-5274-43B4-B6AA-401F62C5F027Q36363799-79C8E1AE-CD05-4B5C-8314-48B5B089F5F6Q37721304-D631D26E-E15B-489F-9921-3BD1266F1EBDQ38157882-4394B9D8-D561-4CB2-B412-6141FAE2BD5AQ38381598-53B862E4-2E9D-4B2E-BC68-C02A94E9A214Q38636217-D54F9751-568B-4FDF-B379-C5CABFE9D7BEQ40045875-00B4AA47-AAED-43F0-B0F4-D62767164913Q45323668-8A96E780-8977-40CD-B533-60FE2236D85DQ47558217-D59D1E88-A02C-48DC-BA0A-AE928D52E881Q49833104-06FB80F9-B19C-4BA2-9DCB-496A049D1147Q51782689-7A2E86AE-6D63-4F1C-94CC-3E9C2E8382D1
P2860
Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plaque reduction neutralizatio ...... n Ratchaburi cohort, Thailand.
@en
Plaque reduction neutralizatio ...... n Ratchaburi cohort, Thailand.
@nl
type
label
Plaque reduction neutralizatio ...... n Ratchaburi cohort, Thailand.
@en
Plaque reduction neutralizatio ...... n Ratchaburi cohort, Thailand.
@nl
prefLabel
Plaque reduction neutralizatio ...... n Ratchaburi cohort, Thailand.
@en
Plaque reduction neutralizatio ...... n Ratchaburi cohort, Thailand.
@nl
P2093
P2860
P921
P356
P1433
P1476
Plaque reduction neutralizatio ...... n Ratchaburi cohort, Thailand.
@en
P2093
Arunee Sabchareon
Chukiat Sirivichayakul
Kriengsak Limkittikul
Sutee Yoksan
P2860
P356
10.1186/1743-422X-11-48
P577
2014-03-12T00:00:00Z